91189-19-4 Usage
Uses
Used in Organic Synthesis:
N-BH-3-aminomethylazetidine is used as a reagent in organic synthesis for its ability to participate in chemical reactions, facilitating the formation of new compounds with desired properties.
Used in Pharmaceutical Development:
In the pharmaceutical industry, N-BH-3-aminomethylazetidine is used as a building block for the development of new boron-based compounds. Its unique structure allows for the creation of molecules with potential therapeutic applications.
Used in Materials Science:
N-BH-3-aminomethylazetidine also finds use in materials science, where it can contribute to the design and synthesis of new materials with specific characteristics, such as improved mechanical properties or novel electronic behaviors.
Overall, the versatility of N-BH-3-aminomethylazetidine stems from its structural features and its boron content, making it a valuable component in the advancement of chemical research and development across multiple disciplines.
Check Digit Verification of cas no
The CAS Registry Mumber 91189-19-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,1,8 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 91189-19:
(7*9)+(6*1)+(5*1)+(4*8)+(3*9)+(2*1)+(1*9)=144
144 % 10 = 4
So 91189-19-4 is a valid CAS Registry Number.
91189-19-4Relevant academic research and scientific papers
AMINOALKYLPYRIMIDINE DERIVATIVES AS HISTAMINE H4 RECEPTOR ANTAGONISTS
-
Page/Page column 52, (2011/07/09)
Aminoalkyipyrimidine derivatives of formula (I), wherein the meaning of the different substituents are those indicated in the description. These compounds are useful as histamine H4 receptor antagonists.
Alpha 1a adrenergic receptor antagonists
-
, (2008/06/13)
This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as alpha 1a adrenergic receptor antagonists. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia are achieved.
